目的: 评估尿毒症门诊血液透析单病种全费用包干结算模式的实践效果,为深化医保支付方式改革、控制医疗费用不合理增长、保障透析患者医疗质量提供实证依据。方法: 基于云南省楚雄州2015—2024年实施尿毒症门诊血液透析全费用包干结算模式改革前后的数据,分析医疗费用、医保基金支出、医疗机构服务行为的变化。结果: 实施尿毒症门诊血液透析全费用包干模式后,门诊血液透析患者月均医疗费用、年度医保基金支出增长率明显放缓,月均个人自付费用显著降低;医疗机构医疗质量得以保障,服务质效稳步提升。结论: 尿毒症门诊血液透析全费用包干结算模式能有效控制门诊血液透析医疗成本,引导医疗机构主动规范诊疗行为,实现了“控成本”与“保质量”的平衡,具有重要的推广价值。
Abstract
Objective: The paper evaluates the practical effect of the single-disease global budget payment model for outpatient hemodialysis in uremia, to provide empirical evidence for deepening the reform of medical insurance payment methods, controlling the unreasonable growth of medical expenses, and ensuring the medical quality of dialysis patients. Methods: Based on pre- and post-implementation data of the global budget payment model for outpatient hemodialysis in Chuxiong Yi Autonomous Prefecture, Yunnan Province from 2015 to 2024, we analyzed changes in medical expenses, medical insurance fund expenditure and medical institution service behaviors. Results: Following the implementation of the global budget payment model for outpatient hemodialysis, the average monthly medical expenses of outpatient hemodialysis patients and the growth rate of annual medical insurance fund expenditure slowed down significantly, while the average monthly out-of-pocket expenses of patients decreased remarkably. Meanwhile, the medical quality of medical institutions was guaranteed, and the service quality and efficiency were improved steadily. Conclusion: The global budget payment model for outpatient hemodialysis in uremia can effectively manage the medical expenses, guide medical institutions to proactively standardize their clinical practices, achieve a balance between "managing expenses" and "ensuring quality", with significant promotion value.
关键词
尿毒症 /
门诊血液透析 /
单病种 /
全费用包干 /
医保支付方式改革 /
实证研究
Key words
uremia /
outpatient hemodialysis /
single-disease payment /
global budget payment /
medical insurance payment reform /
empirical study
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 张路霞,王海燕.中国慢性肾脏病的现状及挑战——来自中国慢性肾脏病流行病学调查的启示[J].中华内科杂志,2012,51(7):497-498.
[2] IQVIA.中国终末期肾病白皮书[R].北京:IQVIA,2023.
[3] 滕兰波,常文秀.终末期肾病血液透析模式的演变及其技术进展[J].实用器官移植电子杂志,2024,12(6):563-567.
[4] 廖元江,石艳,高小玲.重庆市血液透析患者门诊医疗费用分析[J].重庆医学,2021,50(21):3760-3764.
[5] 国家统计局.中国统计年鉴2016[M].北京:中国统计出版社,2017.
[6] 林丽瑜,陈智鸿,李彩凤,等.2021—2022年度厦门市多中心血液透析患者临床质控数据调查分析[J].福建医药杂志,2024,46(5):66-69.
[7] 王辉,汤鸿.地区医保支付方式改革的制度设计及公立医院运营管理的对策建议[J].江苏卫生事业管理,2015,26(4):9-10.
[8] 廖美霞,何佳琳,杨燕绥.美国以价值为导向的肿瘤支付模式介绍及启示[J].中国卫生经济,2020,39(12):110-113.
[9] 中国医药教育协会肾病与血液净化专业委员会血液透析低血压防治专家组.血液透析中低血压防治专家共识(2022)[J].中华内科杂志,2022,61(03):269-281.
[10] 蒲辉,周红丽.血液透析联合血液灌流治疗尿毒症顽固性高血压疗效分析[J].中西医结合肾病杂志,2019,20(2):161-162.
[11] ZHAO D, WANG Y, WANG Y, et al.Randomized control study on hemoperfusion combined with hemodialysis versus standard hemodialysis: effects on middle-molecular-weight toxins and uremic pruritus[J]. Blood Purif. 2022 :1-11.
[12] WU J, LIN L, JIANG X, et al.Characteristics and negative impacts of pleural effusion in hospitalized patients undergoing maintenance hemodialysis[J]. Am J Transl Res. 2022, 14(10):7494-7503.
[13] 陈玉锦,陈西北,连希艳.长期间歇性高效血液透析滤过对维持性血液透析患者营养状况的影响[J].现代医药卫生,2017,33(23):3557-3560.
[14] 陈玉锦,连希艳,陈西北.间歇性高效血液透析滤过对维持性血液透析患者肾性贫血的远期影响[J].实用医学杂志,2016,32(20):3325-3329.
[15] 陈玉锦,陈西北,连希艳.高效on-line血液透析滤过联合血液透析对维持性透析患者生存质量和长期生存率的影响[J].中国血液净化,2016,15(05):280-284+288.
[16] 陈玉锦,王剑松,陈西北.不同医疗保险方式对维持性血液透析患者透析方案选择的影响[J].医学与哲学(B),2015,36(07):92-94.